Unintended effects associated with clinical interventions.

Exclusions: This data class does not include patient safety analyses, internal risk management documentation, or patient safety work product as defined under the Patient Safety and Quality Improvement Act of 2005 (42 U.S.C. 299b 21 et seq.) and implementing regulations (42 CFR part 3). It is not intended to define data elements for the exchange of Patient Safety Organization (PSO) investigations, safety reviews, or facility level reporting activities.

Data Element

Medication Adverse Event

Comment

FDA Context for Adverse Event Reporting Automation Use Case

This comment is to provide additional context by the FDA for specific use case references in the submission above. Adverse event data are critical to supporting the FDA and CDC regulatory missions for safety and effectiveness. As part of the FDA Sentinel Biologics Effectiveness and Safety (BEST) initiative, our team is currently balloting an HL7 Implementation Guide (IG) utilizing the AdverseEvent FHIR resource for mapping adverse event cases from EHR data to Individual Case Safety Report (ICSR) format (https://confluence.hl7.org/display/FHIR/FHIR+Implementation+Guide+for+Transfusion+and+Vaccination+Adverse+Event+Reporting). This work leverages real-world data to detect, validate, and report adverse events. The AdverseEvent resource is a key component, not only of this solution, but for all efforts to incorporate documentation of adverse events into clinical workflow and IT systems – which will benefit patients, providers, researchers, and public health stakeholders. 

Log in or register to post comments

Add a New Comment

Review comment and Submit

Edit
Comment #1
PDF, Doc, Docx
Max Size : 10 MB